-transparent.png){kind=logo}
Some characteristics of vitamin B12 binding and transport in the serum of an infant with congenital hereditary transcobalamin II (TC II) deficiency were studied using the following parameters and methods: vitamin B12 level and binding capacity; electrophoretic mobility in polyacrylamide gel electrophoresis; various immunodiffusion and absorption experiments, using a specific anti-TC II antiserum and the patient's serum as antigen. The results of these studies point to a deficient synthesis of TC II. Parenteral administration of high doses of vitamin B12 was followed by rapid and complete clinical remission and the appearance of vitamin B12 binder in the alpha 2 region which is similar to "fetal binder." Thus, very high concentrations of vitamin B12, either carrier free or bound to this alpha 2 binder, were able to correct the disturbed physiology of TC II deficiency, presumably by normalization of DNA-thymine synthesis.
E Gimpert, and
M Jakob, and
W H Hitzig
October 2019,
BMJ case reports,
E Gimpert, and
M Jakob, and
W H Hitzig
October 1975,
The Journal of biological chemistry,
E Gimpert, and
M Jakob, and
W H Hitzig
December 1979,
British journal of haematology,
E Gimpert, and
M Jakob, and
W H Hitzig
February 1979,
Blood,
E Gimpert, and
M Jakob, and
W H Hitzig
January 1967,
Scandinavian journal of haematology,
E Gimpert, and
M Jakob, and
W H Hitzig
January 2020,
International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition,
E Gimpert, and
M Jakob, and
W H Hitzig
June 1977,
Blood,
E Gimpert, and
M Jakob, and
W H Hitzig
March 2006,
Proceedings of the National Academy of Sciences of the United States of America,
E Gimpert, and
M Jakob, and
W H Hitzig
March 2002,
Clinical chemistry,
E Gimpert, and
M Jakob, and
W H Hitzig
January 1968,
Scandinavian journal of haematology,
